The comparable transcript levels of CXCL10, CCL2, and BCL2, as well as viral loads were observed between control and rIL-22-treated groups (Fig. S4 C and D), indicating that IL-22 was dispensable for the growth, activation, and viral infection of human glial cells. This evidence concerns the gene CCL2 and viral infectious disease.